SAN FRANCISCO--(BUSINESS WIRE)--Miroculus, Inc., a developer of revolutionary tools for personal lab automation, today announced the completion of a Series B extension, bringing the total capital ...

BOSTON--(BUSINESS WIRE)--Miroculus, Inc., a developer of revolutionary tools for personal lab automation, today announced it will host their inaugural “Science Simplified Symposium,” on Thursday, ...

INTEGRA Biosciences is delighted to announce that it has acquired Miroculus, a biotechnology specialist focused on developing hands-off automation solutions for next generation sequencing (NGS) ...

Early detection, we're often told, is the surest way to beat cancer. It's the reason why, year after year, men and women of a certain age dutifully visit their doctors and undergo uncomfortable tests ...

PARSIPPANY, NJ, May 11, 2022 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (OTCQX: IDXG) (“Interpace” or the “Company”), a leader in enabling personalized medicine, has announced that in association ...

Diagnostics startup Miroculus became a bit of a media darling last fall, in part from its TED Talk on bringing inexpensive, rapid-fire cancer diagnostics to the developing world. The Bay Area startup ...

Imagine a simple blood test that can tell you, at the molecular level, the exact type of disease you have and its severity before presenting any symptoms. Miroculus brings an accurate, easy to use, ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...

One of the greatest fears among patients is that a serious condition such as cancer is not picked up until it's too late. If life-threatening diseases could be tested simply, quickly and cheaply - ...

If you have 1 milliliter of blood and about an hour to spare, a 3D-printed, cylindrical device named Miriam can tell you if you have cancer or another kind of disease. This is the wondrous promise ...

Cota Capital and Section 32 join as investors to support the launch of the Miro Canvas, Miroculus’ first commercial platform. SAN FRANCISCO–(BUSINESS WIRE)–February 25, 2021– Miroculus, Inc., a ...